FIGURE 1 Currently, two main classes of GLP-1 RAs are available (Mller et al., 2019
The endogenous glucocorticoids bind to the mineralocorticoid receptors with a 10-fold greater affinity than to the glucocorticoid receptors (79-81)
It is also worth considering that fatigue attributed to GLP-1 therapy may actually reflect underlying conditions such as hypothyroidism, anemia, sleep apnea, or depression, which should be evaluated if tiredness persists
Retatrutide is not yet approved by Health Canada or the FDA as of publication date
People using BPC-157 should not expect substantial reductions in hunger or food cravings
PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and is available through licensed 503A compounding pharmacies across all 50 states without insurance requirements